Sofinnova Management VI, L.L.C.
Insider CIK 1397188 · MRNS 10% owner · OCRX 10% owner · ANTH 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 724,788 | $1.39 | $1.01M | 1,134,851 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 12,528 | $1.39 | $17.4K | 15,470 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | S Sale | 2016-10-20 | 2016-10-24 | 13,367 | $1.39 | $18.6K | 224,845 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | J Other deriv | 2014-08-05 | 2014-08-07 | 524,734 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 28,156 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 636,393 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 2,065,553 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 28,612 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 415,857 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 2,098,937 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 43,785 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | J Other deriv | 2014-08-05 | 2014-08-07 | 103,964 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | J Other deriv | 2014-08-05 | 2014-08-07 | 7,153 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 3,212,038 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion deriv | 2014-08-05 | 2014-08-07 | 409,241 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 494,161 | — | $0 | 494,161 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 6,736 | — | $0 | 6,736 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 322,913 | — | $0 | 817,074 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 63,978 | — | $0 | 161,885 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 4,402 | — | $0 | 11,138 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 317,777 | — | $0 | 1,134,851 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 62,960 | — | $0 | 224,845 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 4,332 | — | $0 | 15,470 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 724,788 | $8.00 | $5.80M | 1,859,639 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 13,367 | $8.00 | $106.9K | 238,212 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2014-08-05 | 2014-08-07 | 12,528 | $8.00 | $100.2K | 27,998 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | C Conversion | 2014-08-05 | 2014-08-07 | 97,907 | — | $0 | 97,907 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2014-03-18 | 2014-03-20 | 338,370 | — | $0 | 686,994 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2014-03-18 | 2014-03-20 | 4,612 | — | $0 | 9,364 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | J Other | 2014-03-18 | 2014-03-20 | 67,040 | — | $0 | 136,112 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-17 | 322,809 | $6.03 | $1.95M | 1,025,364 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-17 | 63,957 | $6.03 | $385.7K | 203,152 | SEC↗ |
| OCRX Ocera Therapeutics, Inc. | P Buy | 2013-07-15 | 2013-07-17 | 4,400 | $6.03 | $26.5K | 13,976 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2011-12-30 | 2012-01-03 | 280 | $6.23 | $1.7K | 44,969 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2011-12-30 | 2012-01-03 | 4,090 | $6.23 | $25.5K | 653,550 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2011-12-30 | 2012-01-03 | 20,630 | $6.23 | $128.5K | 3,298,684 | SEC↗ |